Pegintron maintenance therapy in cirrhotic (Metavir F4) HCV patients, who failed to respond to Interferon/Ribavirn (IR) therapy: final results of the EPIC3 cirrhosis maintenance trial
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.